|
|
Canadian Markets for Peripheral Vascular DevicesPublished by: Millennium Research Published: Jan. 1, 2006 Table of Contents
LIST OF EXHIBITS EXECUTIVE SUMMARY Exhibit ES-1: PV Device Market, by Device, Canada, 2004 Exhibit ES-2: PV Device Market, by Device, As a % of Total, Canada, 2003- 2009 Exhibit ES-3: PV Stent Market, by Indication, As a % of Total, Canada, 2003- 2009 Exhibit ES-4: PTA Balloon Catheter Market, by Type, Canada, 2003-2009 Exhibit ES-5: Carotid Stenting Procedures and Adoption of EPDs, Canada, 2003-2009 Exhibit ES-6: Inferior Vena Cava Filter Market, by Type, Canada, 2003-2009 Exhibit ES-7: Endovascular Aortic Repair Procedures, by Type, Canada, 2003- 2009 Exhibit ES-9: PV Diagnostic and Interventional Procedures, Canada, 2003- 2009 Exhibit ES-10: Leading Competitors in the PV Market, Canada, 2005 CHAPTER 1: CANADIAN PERIPHERAL VASCULAR DEVICE OVERVIEW Exhibit 1-1: PV Device Market, Canada (US$), 2003-2009 Exhibit 1-2: PV Device Market, by Type, Canada (US$), 2003-2009 (Tabular Format) Exhibit 1-3: PV Device Market, by Type, Canada (CD$), 2003-2009 Exhibit 1-4: PV Device Market Growth, by Type, Canada, 2004-2009 Exhibit 1-5: PV Device Market, by Type, Canada (US$), 2003-2009 (Graphical Format) Exhibit 1-6: Drivers and Limiters of the PV Device Market, Canada Exhibit 1-7: Over-50s as a % of the Total Population, Canada versus United States, 2000-2025 Exhibit 1-8: Obesity as a Percentage of Population Aged 20-64, by Province, Canada, 1994-2001 Exhibit 1-9: Canadian Medical Device Approval Overview Exhibit 1-10: Regulatory Status of Carotid Stents and EPDs Exhibit 1-11: SFA Treatment, by Device, Canada, 2003-2009 Exhibit 1-12: Canadian PV Procedures, by Physician Specialty Exhibit 1-13: Leading Competitors in the Canadian PV Device Market, 2005 CHAPTER 2: PERIPHERAL VASCULAR STENT MARKET Exhibit 2-1: PV Stent Market, Canada (US$), 2003-2009 Exhibit 2-2: Lower Extremity Atherosclerosis Diagnosis, Canada, 2003-2009 Exhibit 2-3: Lower Extremity Atherosclerosis Diagnosis, by Method, Canada, 2003 Exhibit 2-4: PV Stent Procedures and Units, by Indication, Canada, 2003-2009 Exhibit 2-5: PV Stent Market, by Indication, Canada (US$), 2003-2009 (Tabular Format) Exhibit 2-6: PV Stent Market, by Indication, Canada (CD$), 2003-2009 Exhibit 2-7: PV Stent Market Growth, by Indication, Canada, 2004-2009 Exhibit 2-8: PV Stent Units and Market Value, by Indication, As a % of Total, Canada, 2003-2009 Exhibit 2-9: PV Stent Market, by Indication, Canada (US$), 2003-2009 (Graphical Format) Exhibit 2-10: Drivers of the PV Stent Market, Canada Exhibit 2-11: Limiters of the PV Stent Market, Canada Exhibit 2-12: BX and SX PV Stent Use, Segmented by Indication, Canada, 2004 Exhibit 2-13: Leading Competitors in the PV Stent Market, Canada, 2005 CHAPTER 3: PTA BALLOON CATHETER MARKET Exhibit 3-1: PTA Balloon Catheter Market, Canada (US$), 2003-2009 Exhibit 3-2: PTA Balloon Catheter Device Overview Exhibit 3-3: PTA Balloon Catheter Procedures and Units, by Use, Canada, 2003-2009 Exhibit 3-4: PTA Balloon Catheter Procedures, by Type and Use, As a % of Total, Canada, 2004 Exhibit 3-5: PTA Balloon Catheter Procedure and Unit Growth, by Use, Canada, 2004-2009 Exhibit 3-6: PTA Balloon Catheter Market, by Type, Canada (US$), 2003-2009 (Tabular Format) Exhibit 3-7: PTA Balloon Catheter Market, by Type, Canada (CD$), 2003-2009 Exhibit 3-8: PTA Balloon Catheter Market Growth, by Type, Canada, 2004- 2009 Exhibit 3-9: PTA Balloon Catheter Market, by Type, Canada (US$), 2003-2009 (Graphical Format) Exhibit 3-10: Drivers of the PTA Balloon Catheter Market, Canada Exhibit 3-11: Limiters of the PTA Balloon Catheter Market, Canada Exhibit 3-12: Leading Competitors in the PTA Balloon Catheter Market, Canada, 2005 CHAPTER 4: EMBOLIC PROTECTION DEVICE MARKET Exhibit 4-1: EPD Market, Canada (US$), 2003-2009 Exhibit 4-2: Advantages and Disadvantages of EPDs, by Type Exhibit 4-3: Advantages and Disadvantages of EPDs, by Type (Continued) Exhibit 4-4: EPD Market and Growth, Canada (US$ and CD$), 2003-2009 Exhibit 4-5: Drivers of the EPD Market, Canada Exhibit 4-6: Limiters of the EPD Market, Canada Exhibit 4-7: Capture Efficiencies of Leading Filter Basket EPDs Exhibit 4-8: Important Carotid Stenting with EPD Trial Results Exhibit 4-9: Overview of Carotid Stenting with EPD Trials Exhibit 4-10: Leading Competitors in the EPD Market, Canada, 2005 Exhibit 4-11: Overview of EPDs Exhibit 4-12: Overview of EPDs (Continued) CHAPTER 5: INFERIOR VENA CAVA FILTER MARKET Exhibit 5-1: IVCF Market, Canada (US$), 2003-2009 Exhibit 5-2: Indications for IVCF Placement Exhibit 5-3: Complications Associated with IVCF Use Exhibit 5-4: IVCF Market, by Type, Canada (US$), 2003-2009 (Tabular Format) Exhibit 5-5: IVCF Market, by Type, Canada (CD$), 2003-2009 Exhibit 5-6: IVCF Market Growth, by Type, Canada, 2004-2009 Exhibit 5-7: IVCF Market, by Type, Canada (US$), 2003-2009 (Graphical Format Exhibit 5-8: Indicated Safe Time of Removal for Retrievable IVCFs, 2004 Exhibit 5-9: Drivers of the IVCF Market, Canada Exhibit 5-10: Limiters of the IVCF Market, Canada Exhibit 5-11: Leading Competitors in the IVCF Market, Canada, 2005 CHAPTER 6: AORTIC STENT GRAFT MARKET Exhibit 6-1: Aortic Stent Graft Market, Canada (US$), 2003-2009 Exhibit 6-2: AAA Stent Graft Device Overview, Canada, 2005 Exhibit 6-3: US FDA Approved AAA Stent Graft Clinical Trial Overview Exhibit 6-4: Thoracic Stent Graft Device Overview, Canada, 2005 Exhibit 6-5: Rupture Risk of Untreated AAA Exhibit 6-6: Stent Graft Procedures, by Indication, Canada, 2003-2009 Exhibit 6-7: Aortic Stent Graft Market, by Indication, Canada (US$), 2003-2009 Exhibit 6-8: Aortic Stent Graft Market, by Indication, Canada (CD$), 2003-2009 Exhibit 6-9: Aortic Stent Graft Market Growth, by Indication, Canada, 2004-2009 Exhibit 6-10: AAA Procedures, by Type, Canada, 2003-2009 Exhibit 6-11: AAA Stent Graft Penetration into Total AAA Procedures, Canada, 2003-2009 Exhibit 6-12: AAA Endoleak Categories and Descriptions Exhibit 6-13: Drivers of the Aortic Stent Graft Market, Canada Exhibit 6-14: Limiters of the Aortic Stent Graft Market, Canada Exhibit 6-15: Leading Competitors in the Canadian Aortic Stent Graft Market, by Type, 2005 CHAPTER 7: ACCESSORY DEVICE MARKET Exhibit 7-1: Accessory Device Market, Canada (US$), 2003-2009 Exhibit 7-2: PV Accessory Device Market, by Type, Canada (US$), 2003-2009 (Tabular Format) Exhibit 7-3: PV Accessory Device Market, by Type, Canada (CD$), 2003-2009 Exhibit 7-4: PV Accessory Device Market Growth, by Type, Canada, 2004-2009 Exhibit 7-5: PV Accessory Device Market, by Type, Canada (US$), 2003-2009 (Graphical Format) Exhibit 7-6: Drivers of the PV Accessory Device Market, Canada Exhibit 7-7: Limiters of the PV Accessory Device Market, Canada Exhibit 7-8: Leading Competitors in the Accessory Device Market, Canada, 2005 AbstractThe global peripheral vascular (PV) device market is valued at over $2 billion. Substantial market growth will occur because the aging population is driving an increase in both diagnostic and interventional PV procedures. Procedure volumes have also been fueled by increased screening, detection, and public awareness of PV diseases. Several key segments are driving growth in the PV market. These segments include the markets for PV stents, as well as abdominal aortic aneurysm (AAA) and thoracic stent grafts. These factors will combine to drive PV device revenues to over $3 billion in 2010. MRG’s Global Markets for Peripheral Vascular Devices 2006 report series provides you with key market drivers, industry trends, and unsurpassed segmentation. Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||